Next Article in Journal
Investigation of the Impact of Manufacturing Methods on Protein-Based Long-Acting Injectable Formulations: A Comparative Assessment for Microfluidics vs. Conventional Methods
Previous Article in Journal
Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia
Previous Article in Special Issue
Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(10), 1263; https://doi.org/10.3390/pharmaceutics16101263
Action Date Notes Link
article pdf uploaded. 27 September 2024 16:03 CEST Version of Record https://www.mdpi.com/1999-4923/16/10/1263/pdf-vor
article xml file uploaded 29 September 2024 09:25 CEST Original file -
article xml uploaded. 29 September 2024 09:25 CEST Update https://www.mdpi.com/1999-4923/16/10/1263/xml
article pdf uploaded. 29 September 2024 09:25 CEST Updated version of record https://www.mdpi.com/1999-4923/16/10/1263/pdf
article html file updated 29 September 2024 09:28 CEST Original file https://www.mdpi.com/1999-4923/16/10/1263/html
Back to TopTop